Features

Abbott's XIENCE family of drug eluting stents (which includes XIENCE V®, XIENCE PRIME™ and XIENCE nano™) is the worldwide drug eluting stent market leader for the treatment of coronary artery disease

Partnership announced in connection with coordinated global effort by industry, Gates Foundation, WHO and others.

Abbott's Longford, Ireland, facility has been manufacturing medical diagnostic tests for global markets since 2005.

Abbott delivered its fifth consecutive year of double-digit ongoing earnings per share (EPS) growth with sales increasing more than 10 percent to $38.9 billion in 2011 driven by strong performance across its diverse businesses, particularly in emerging markets.

Abbott Nutrition and the Abbott Fund are teaming with nonprofit organization Partners in Health to fight hunger in Haiti by building a new facility to produce Nourimanba, a peanut-based, therapeutic food for the treatment of severe malnutrition in children.

The U.S. Food and Drug Administration (FDA) has selected Abbott's STARLIMS software-based laboratory information management system (LIMS) as part of an initiative to enhance its own testing laboratories.

Abbott employees continued to expand their support for non-profit groups in 2011, setting new company records for giving.

At the 7th Annual China Corporate Citizenship Conference in Beijing, Abbott recently received several awards for its citizenship work, including the prestigious “2011 China Best Corporate Citizenship Award" for its overall responsible approach to business in China.  

In a recent hearing of the United States House of Representatives' Subcommittee on Research and Science Education (part of the larger Science and Technology committee), Abbott scientist Jennifer Jones testified on how transferring knowledge from the workplace to the classroom advances science, technology, engineering and mathematics (STEM) education for children of all ages, from kindergarten to 12th grade.

Promoting environmental conservation, Chicago's Field Museum has opened the Abbott Hall of Conservation Restoring Earth, a permanent exhibit sponsored by Abbott.

Scrip, a leading global pharmaceutical and biotech news organization, honored Abbott and the Abbott Fund, the company's philanthropic foundation, with a 2011 Scrip Award for Corporate Social Responsibility (CSR) at its seventh annual awards ceremony in London.

Abbott is one of the recipients of the "Tell Awards" for Switzerland's most significant inward investment projects from the Americas region in 2010.

Abbott in Brazil recently launched its volunteer program, building on an existing global partnership with Operation Smile, a global organization that provides free reconstructive surgery to children and young adults with facial deformities.

Abbott has launched a new Twitter feed to expand our distribution of current news and information related to the company.

Abbott, one of Ireland's largest multinational companies with 14 facilities in seven counties, has published its first citizenship report for Ireland.

Citing Abbott leadership in emerging markets, U.S. magazine The Deal has named Abbott one of its "Most Admired Corporate Dealmakers" for the fourth consecutive year.

For the seventh year in a row, Abbott has been named to the Dow Jones Sustainability Index (DJSI) – on both the North America and World lists – for continued leadership in responsible economic, environmental and social performance.

The Abbott Fund, Abbott's philanthropic foundation, recently donated $100,000 to humanitarian organizations working in Somalia, Ethiopia and Kenya to assist those impacted by the devastating drought and famine in those countries, where more than 12.4 million people are urgently in need of humanitarian assistance.

Abbott continued to garner recognition as a top employer, according to several 2011 annual surveys conducted by independent organizations.